Neurocrine Biosciences Inc (NASDAQ:NBIX)

84.27
Delayed Data
As of Feb 23
 -1.15 / -1.35%
Today’s Change
39.21
Today|||52-Week Range
91.82
+8.61%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close85.42
Today’s open85.53
Day’s range82.63 - 86.05
Volume554,049
Average volume (3 months)968,207
Market cap$7.5B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+0.61%
Earnings growth (this year)+90.71%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+977.51%
P/E ratioNM
Price/Sales42.29
Price/Book20.11

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp-2.62-5.82%
TECHBio-Techne Corp+2.49+1.78%
JUNOJuno Therapeutics In...+0.02+0.02%
BLUEbluebird bio Inc+4.85+2.41%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)$0.16
Annual revenue (last year)$161.6M
Annual profit (last year)-$142.5M
Net profit margin-88.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts